Molecular classification of acute myeloid leukemia (AML) aids prognostic stratification and clinical management. Our aim in this study is to identify transcriptome-wide mRNAs that are specific to each of the molecular subtypes of AML. We analyzed RNA-sequencing data of 955 AML samples from three cohorts, including the BeatAML project, the Cancer Genome Atlas, and a cohort of Swedish patients to provide a comprehensive transcriptome-wide view of subtype-specific mRNA expression. We identified 729 subtype-specific mRNAs, discovered in the BeatAML project and validated in the other two cohorts. Using unique proteomics data, we also validated the presence of subtype-specific mRNAs at the protein level, yielding a rich collection of potential pr...
Acute myeloid leukaemia (AML) is a heterogeneous disease characterised by clonal malignant haematopo...
Acute myeloid leukaemia (AML) is a heterogeneous disease characterised by clonal malignant haematopo...
Transcriptional profiling of acute leukemia, specifically by RNA-sequencing or whole transcriptome s...
Molecular classification of acute myeloid leukemia (AML) aids prognostic stratification and clinical...
Molecular classification of acute myeloid leukemia (AML) aids prognostic stratification and clinical...
Molecular classification of acute myeloid leukemia (AML) aids prognostic stratification and clinical...
Gene expression profiling (GEP) is a well-established indispensable tool used to study hematologic m...
Acute myeloid leukemia (AML) is an aggressive blood cancer with a poor prognosis. We report a compre...
Acute myeloid leukemia (AML) is an aggressive blood cancer with a poor prognosis. We report a compre...
Over the past decades, the outlook for patients with AML has improved as a result of refinements in ...
We examined the gene expression profiles of two independent cohorts of patients with acute myeloid l...
We examined the gene expression profiles of two independent cohorts of patients with acute myeloid l...
Acute myeloid leukaemia (AML) is a heterogeneous disease characterised by clonal malignant haematopo...
Transcriptional profiling of acute leukemia, specifically by RNA-sequencing or whole transcriptome s...
Acute myeloid leukaemia (AML) is a heterogeneous disease characterised by clonal malignant haematopo...
Acute myeloid leukaemia (AML) is a heterogeneous disease characterised by clonal malignant haematopo...
Acute myeloid leukaemia (AML) is a heterogeneous disease characterised by clonal malignant haematopo...
Transcriptional profiling of acute leukemia, specifically by RNA-sequencing or whole transcriptome s...
Molecular classification of acute myeloid leukemia (AML) aids prognostic stratification and clinical...
Molecular classification of acute myeloid leukemia (AML) aids prognostic stratification and clinical...
Molecular classification of acute myeloid leukemia (AML) aids prognostic stratification and clinical...
Gene expression profiling (GEP) is a well-established indispensable tool used to study hematologic m...
Acute myeloid leukemia (AML) is an aggressive blood cancer with a poor prognosis. We report a compre...
Acute myeloid leukemia (AML) is an aggressive blood cancer with a poor prognosis. We report a compre...
Over the past decades, the outlook for patients with AML has improved as a result of refinements in ...
We examined the gene expression profiles of two independent cohorts of patients with acute myeloid l...
We examined the gene expression profiles of two independent cohorts of patients with acute myeloid l...
Acute myeloid leukaemia (AML) is a heterogeneous disease characterised by clonal malignant haematopo...
Transcriptional profiling of acute leukemia, specifically by RNA-sequencing or whole transcriptome s...
Acute myeloid leukaemia (AML) is a heterogeneous disease characterised by clonal malignant haematopo...
Acute myeloid leukaemia (AML) is a heterogeneous disease characterised by clonal malignant haematopo...
Acute myeloid leukaemia (AML) is a heterogeneous disease characterised by clonal malignant haematopo...
Transcriptional profiling of acute leukemia, specifically by RNA-sequencing or whole transcriptome s...